BioCentury
ARTICLE | Financial News

Zymeworks raises $10.9M

September 7, 2012 1:11 AM UTC

Zymeworks Inc. (Vancouver, B.C.) raised $10.9 million in a financing led by Advanced Biotechnologies Venture Fund. New and existing private investors also participated. Zymeworks is developing its AbluCORE Scaffold, a multi-valent targeting platform based on human serum albumin. AbluCORE is in preclinical testing for cancer and inflammatory diseases. ...